Targeting the gut to treat multiple sclerosis
Medical clearance through fax was once standard operating procedure, but this practice should no longer be observed due to the inadequacy of the communication, lack of patient evaluation, and security risks
Opara EI, Chohan M
Assuno SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, et al
This work was supported by JSPS KAKENHI Grants Number 16K07743 and 19H02913 (to N.H.) and 19K05866 (to H.I.), the Urakami Foundation for Food and Food Culture Promotion (to N.H.), and the National Center for Complementary and Integrative Health of the National Institutes of Health award R01AT006896 (to C.S.)
A class with meaningful differences between drugs Semaglutide targets GLP-1 receptors specifically, while tirzepatide hits both GLP-1 and a second receptor called GIP, which partly explains why tirzepatide tends to produce larger average weight loss in trials